Gain Therapeutics CEO Gene Mack takes interim CFO role after Fuggetta resignation

• Gain Therapeutics named President and CEO Gene Mack interim CFO effective Oct. 1, 2026.
• Senior Vice President of Finance Gianluca Fuggetta will step down as principal financial and accounting officer on Sept. 30, 2026.
• Mack will take over principal financial and accounting duties on an interim basis while the company searches for a permanent replacement.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gain Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-111391), on September 28, 2026, and is solely responsible for the information contained therein.